Clinical Characterization and Prognostic Risk Factors of Susac Syndrome
Current treatment strategies for SuS do not fully prevent relapses. Severe brain manifestation at onset, male sex, and high CSF protein levels are risk factors of a worse prognosis of disability and dependence, indicating the need for intensive treatment. High-frequency hearing loss does not exclude SuS diagnosis.
Authors
- Eitan Auriel (ORCID: https://orcid.org/0000-0001-6712-5156)
- Victoria Furer (ORCID: https://orcid.org/0000-0001-5193-4207)
- Keren Regev (ORCID: https://orcid.org/0000-0003-4556-3299)
- Dinah Zur (ORCID: https://orcid.org/0000-0003-1147-444X)
- Zohar Habot‐Wilner (ORCID: https://orcid.org/0000-0002-1058-0286)
- Itay Lotan (ORCID: https://orcid.org/0000-0002-4015-9783)
- Adi Wilf‐Yarkoni (ORCID: https://orcid.org/0000-0002-2584-5793)
- Lior Fuchs (ORCID: https://orcid.org/0000-0003-4537-8659)
- Nitai Shimon
- Ifat Vigiser (ORCID: https://orcid.org/0000-0003-2711-8327)
- Ori Elkayam (ORCID: https://orcid.org/0000-0001-9329-3639)
- Arnon Karni (ORCID: https://orcid.org/0000-0002-5625-7900)
- Mark Andrew Hellmann (ORCID: https://orcid.org/0000-0002-0010-9407)
- Yahav Oron (ORCID: https://orcid.org/0000-0003-2356-9147)
- Hadar Kolb (ORCID: https://orcid.org/0000-0002-4178-5858)
- Robert M. Rennebohm
Institutions
- Cleveland Clinic (US)
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Rabin Medical Center (IL)
- Assaf Harofeh Medical Center (IL)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1212/nxi.0000000000200357
- Citations
- 4
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 2.15